Constance Therapeutics has a total of 22 patents globally, out of which 7 have been granted. Of these 22 patents, more than 59% patents are active. The United States of America is where Constance Therapeutics has filed the maximum number of patents, followed by Israel and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Constance Therapeutics.
Constance Therapeutics was founded in 2015. Constance Therapeutics specializes in creating comprehensive cannabis extracts derived from the entire cannabis plant, emphasizing an integrative approach to treatment.
Do read about some of the most popular patents of Constance Therapeutics which have been covered by us in this article and also you can find Constance Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Constance Therapeutics patent portfolio.
How many patents does Constance Therapeutics have?
Constance Therapeutics has a total of 22 patents globally. These patents belong to 2 unique patent families. Out of 22 patents, 13 patents are active.
How Many Patents did Constance Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Constance Therapeutics Applications Filed | Constance Therapeutics Patents Granted |
2023 | – | 1 |
2021 | 2 | 3 |
2020 | 1 | 1 |
2019 | 1 | 2 |
2018 | 3 | – |
2017 | 2 | – |
2016 | 13 | – |
How many Constance Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Constance Therapeutics File in Different Countries?
Countries in which Constance Therapeutics Filed Patents
Country | Patent |
United States Of America | 6 |
Israel | 3 |
Australia | 3 |
Mexico | 2 |
Canada | 2 |
Europe | 2 |
Colombia | 1 |
Where are Research Centers of Constance Therapeutics Patents Located?
The Research Centers of Constance Therapeutics Patents is the United States of America.
Best Constance Therapeutics Patents
WO2016123475A1 is the most popular patent in the Constance Therapeutics portfolio. It has received 43 citations so far from companies like Kanabo Research, Visceral Therapeutics, Fog Atomic Technologies.
Below is the list of most cited patents of Constance Therapeutics:
Publication Number | Citation Count |
WO2016123475A1 | 43 |
WO2017091764A1 | 32 |
US10806707B2 | 8 |
US10238745B2 | 7 |
CA3006182A1 | 3 |
CA2974292A1 | 2 |
US10406186B2 | 2 |
US10940173B2 | 1 |
What Percentage of Constance Therapeutics US Patent Applications Were Granted?
Constance Therapeutics (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100%.
Below are the key stats of Constance Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Constance Therapeutics?
Law Firm | Total Applications | Success Rate |
Kilpatrick Townsend & Stockton Llp | 3 | 100% |
Clark Hill | 1 | 100% |
List of Constance Therapeutics patents
Constance Therapeutics Patents | Title |
MX386351B | Methods For The Preparation Of Cannabis Oil Extracts And Compositions. |
MX385238B | Cannabis Oil Compositions And Methods For Preparing The Same. |
EP3380096A4 | Cannabis Oil Compositions And Methods For Preparation Thereof |
EP3250200A4 | Methods For Preparation Of Cannabis Oil Extracts And Compositions |
CA3006182A1 | Cannabis Oil Compositions And Methods For Preparation Thereof |
CA2974292A1 | Methods For Preparation Of Cannabis Oil Extracts And Compositions |
AU2021203916B2 | Methods For Preparation Of Cannabis Oil Extracts And Compositions |
IL299047A | Cannabis Oil Compositions And Methods For Preparation Thereof |
IL259571A | Cannabis Oil Compositions And Methods For Preparation Thereof |
IL253664A | Methods For Preparation Of Cannabis Oil Extracts And Compositions |
US10940173B2 | Cannabis Oil Extracts And Compositions |
US10806707B2 | Cannabis Oil Compositions And Methods For Preparation Thereof |
US10406186B2 | Cannabis Oil Extracts And Compositions |
CO20180006452A2 | Cannabis Oil Compositions And Methods For Preparing The Same |
WO2019074959A1 | Cannabinoid Composition And Products Including Alpha-Tocopherol |
AU2016359160A1 | Cannabis Oil Compositions And Methods For Preparation Thereof |
AU2016211314A1 | Methods For Preparation Of Cannabis Oil Extracts And Compositions |
WO2017091764A1 | Cannabis Oil Compositions And Methods For Preparation Thereof |
WO2016123475A1 | Methods For Preparation Of Cannabis Oil Extracts And Compositions |
US10238745B2 | Cannabinoid Composition And Products Including Α-Tocopherol |
US20220031781A1 | Cannabis Oil Extracts And Compositions |
US20210275465A1 | Cannabis Oil Compositions And Methods For Preparation Thereof |
What are Constance Therapeutics key innovation segments?
What Technologies are Covered by Constance Therapeutics?
The chart below distributes patents filed by Constance Therapeutics